Pharmaceutical Companies
Adlai Nortye Ltd
π°πΎCayman Islands
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $110.5M
- Website
- -
Invivyd
πΊπΈUnited States
Invivyd, Inc.(formerly Adagio Therapeutics, Inc.) engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize...
Journey Medical
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- 58
- Market Cap
- $109.6M
- Website
- -
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane,...
Nectar Lifesciences
πΊπΈUnited States
- Ownership
- -
- Established
- 1995-01-01
- Employees
- -
- Market Cap
- $109.5M
- Website
- -
Anixa Biosciences, Inc.
πΊπΈUnited States
Citius Pharmaceuticals
πΊπΈUnited States
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and...
REGENCELL BIOSCIENCE LIMITED
ππ°Hong Kong, China
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $106.9M
- Website
- -
Renovaro
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- 12
- Market Cap
- $106.1M
- Website
- -
Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists...
Verrica Pharmaceuticals
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- 100
- Market Cap
- $104.9M
- Website
- -
IO Biotech
π©π°Denmark
- Ownership
- -
- Established
- -
- Employees
- 68
- Market Cap
- $104.7M
- Website
- -
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target...
